Uterine sarcomas are very infrequent and heterogeneous entities. Due to its rarity, pathological diagnosis, surgical management, and systemic treatment are challenging. Treatment decision process in these tumors should be taken in a multidisciplinary tumor board. Available evidence is low and, in many cases, based on case series or clinical trials in which these tumors have been included with other soft tissue sarcoma. In these guidelines, we have tried to summarize the most relevant evidence in the diagnosis, staging, pathological disparities, surgical management, systemic treatment, and follow-up of uterine sarcomas.
CITATION STYLE
Pérez-Fidalgo, J. A., Ortega, E., Ponce, J., Redondo, A., Sevilla, I., Valverde, C., … Sebio, A. (2023, January 1). Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Therapeutic Advances in Medical Oncology. SAGE Publications Inc. https://doi.org/10.1177/17588359231157645
Mendeley helps you to discover research relevant for your work.